Log in to save to my catalogue

Serum levels of lipoprotein-associated phospholipase A2 are associated with coronary atherosclerotic...

Serum levels of lipoprotein-associated phospholipase A2 are associated with coronary atherosclerotic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_340dcd7bba4d451e9b075604bc7e7d99

Serum levels of lipoprotein-associated phospholipase A2 are associated with coronary atherosclerotic plaque progression in diabetic and non-diabetic patients

About this item

Full title

Serum levels of lipoprotein-associated phospholipase A2 are associated with coronary atherosclerotic plaque progression in diabetic and non-diabetic patients

Publisher

England: BioMed Central Ltd

Journal title

BMC cardiovascular disorders, 2024-05, Vol.24 (1), p.251-9, Article 251

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Lp-PLA2 is linked to cardiovascular diseases and poor outcomes, especially in diabetes, as it functions as a pro-inflammatory and oxidative mediator.
This research aimed to explore if there is a connection between the serum levels of Lp-PLA2 and the progression of coronary plaques (PP) in individuals with type 2 diabetes mellitus (T2DM) and thos...

Alternative Titles

Full title

Serum levels of lipoprotein-associated phospholipase A2 are associated with coronary atherosclerotic plaque progression in diabetic and non-diabetic patients

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_340dcd7bba4d451e9b075604bc7e7d99

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_340dcd7bba4d451e9b075604bc7e7d99

Other Identifiers

ISSN

1471-2261

E-ISSN

1471-2261

DOI

10.1186/s12872-024-03931-x

How to access this item